A Randomized Double-blind Placebo-controlled Phase 3 Study to
Evaluate the Effect of Remetirom on Liver-Related OUtcomes in
Patients with Well-compensated (Child-Pugh A) Non-alcoholic
Steatohepatitis (NASH) Cirrhosis (MAESTRO-NASH OUTCOMES)
Please contact us for more information or to learn if you are eligible to participate.
